title: STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
authors.affiliation: Stanford University Medical Center, Stanford, CA, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Ohgami
authors.forename: L
authors.initials: L
authors.lastname: Ma
authors.forename: J D
authors.initials: JD
authors.lastname: Merker
authors.forename: B
authors.initials: B
authors.lastname: Martinez
authors.forename: J L
authors.initials: JL
authors.lastname: Zehnder
authors.forename: D A
authors.initials: DA
authors.lastname: Arber
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics*; D001853:Bone Marrow / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017730:Ki-1 Antigen / Q000378:metabolism*; D054066:Leukemia, Large Granular Lymphocytic / Q000235:genetics*; D008198:Lymph Nodes / Q000378:metabolism; D016399:Lymphoma, T-Cell / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D050796:STAT3 Transcription Factor / Q000235:genetics*; D012867:Skin / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D017730:Ki-1 Antigen; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human